Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation
Published in J Am Coll Cardiol, 2025
Top-decile (D1) journal.
Recommended citation: Bonanad-Lozano C, García Blas S, Amat-Santos I, Gonzalez-Manzanares R , Sanchís J, López Otero D, Nombela Franco L, Gheorge L, Sanz-Sánchez J, Baladrón Zorita C, Iñiguez Romo A, Muñoz García AJ, Vilalta V, Ojeda S, Veiga Fernández G, Córdoba Soriano JG, Cepas P, Sandín Rollán M, Ríos XF, Palma-Carbajal R, Martín Reyes R, Romaguera R, Avanzas P, Franco-Peláez JA, Martín Moreiras J, Gonzalez Juanatey JR, Tirado G, Calle G, Díez JL, Santos-Martínez S, Domínguez Erquicia P, García EM, Fernandez-Nofrerias E, López País J, Gonzalo N, Barri AG, Asmarats L, López Pérez M, Domínguez Rodríguez LM, Cobo M, González Bermúdez I, García Álvarez A, García Pavía P, Fuster V, Ibáñez B, Raposeiras-Roubín S. Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. J Am Coll Cardiol. 2025 Oct 14;86(15):1128-1138. doi: 10.1016/j.jacc.2025.07.051. PMID: 41062227.
Download Paper